ロード中...
Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734
Bromodomain and extra-terminal domain (BET) proteins, cyclic adenosine monophosphate response element-binding protein (CBP), and the E1A-binding protein of p300 (EP300) are important players in histone acetylation. Preclinical evidence supports the notion that small molecules targeting these protein...
保存先:
| 出版年: | Blood Adv |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7479962/ https://ncbi.nlm.nih.gov/pubmed/32882003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001879 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|